ANAGENICS LIMITED — Director's Dealing 2015

Aug 12, 2015

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	Cellmid Limited
ABN	69 111 304 119

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Edward Fintan Walton
Date of last notice	23 July 2015

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

purposes of seName of DirDate of lastPart 1 - Chan		ction 205G of the Corporations Act.
	Name of Dir	ector	Dr Edward Fintan	Walton
	Date of last	notice	23 July 2015
		ge of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the reNote: In the case of a company, interests which come within paragraph (i) of the definition o				sponsible entitf “notifiable inte	y of the trustrest of a director” should be disclosed in this p
	Direct or in	direct interest	Direct
	Nature of in(including r	direct interestegistered holder)	N/A
	Note: Provide detthe relevant intere	ails of the circumstances giving rise tost.
	Date of chan	ge	10 August 2015
	No. of secur	ities held prior to change	Nil
	Class		Ordinary Fully Paid
	Number acq	uired	300,000
	Number dis	posed	NIL
	Value/ConsiNote: If considerestimated valuatio	derationation is non-cash, provide details andn	$10,640

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change 300,000 fully paid ordinary shares Nature of change On market purchase Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 – + Closed period

Were the interest in the securities or contracts detailed above traded No during a + closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed N/A during this period? If prior written clearance was provided, on what date was this provided? N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002